Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer
Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer have?
Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer has 41 citations in the OpenAlex counts ScholarIQ stores.
When was Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer published?
Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer has 2021 year in the ScholarIQ index.
What is the open-access status of Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer?
Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer has closed oa status in the ScholarIQ index.
What is the DOI of Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer?
The DOI for Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer is on the source record.
What is the PMID of Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer?
The PMID for Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer is on the source record.
What is the OpenAlex record for Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer?
The OpenAlex for Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer is on the source record.